EUCTR2014-004895-48-DE进行中（未招募）1 期
Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology and Metabolic Control in Patients with Type 2 Diabetes Mellitus on Stable Metformin Treatment
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Male or female subject with diabetes mellitus type 2
- •2. Diabetes mellitus type 2 on stable treatment with metformin (daily dose at least 1000 mg) for at least 6 months
- •3. HbA1c 7.0%–9.9%, both inclusive
- •4. Diabetes duration of at least 24 months)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 32
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 12
排除标准
- •1. History of diabetes mellitus type 1
- •2. GFR (as calculated by the Cockroft-Gault equation) < 60 ml/min at Screening
- •3. Systolic blood pressure outside the range of 100–160 mmHg or diastolic blood pressure above 95 mmHg at Screening
研究者
相似试验
招募中
2 期
Effect of Linagliptin and Empagliflozine on diabetesIRCT20221016056201N1Arak University of Medical Sciences55
招募中
3 期
Effect of Linagliptin on Diabetic patients with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20210812052156N1Gonabad University of Medical Sciences70
进行中（未招募）
不适用
Effect of Linagliptin in comparison with Glimepiride as add on to Metformin on the metabolism of diabetic patients after a meal.Diabetes mellitus type 2 on metformin therapyMedDRA version: 14.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2012-000179-17-DEikfe GmbH
尚未招募
Unknown
Comparative in vivo evaluation of 2 Empagliflozin 10 mg Combined Linagliptin 5 mg Tablet formulations.IRCT20180620040164N69Cosar Pharmaceutical Co.24
尚未招募
Unknown
Comparative in vivo evaluation of 2 Empagliflozin 25 mg Combined Linagliptin 5 mg Tablet formulations.IRCT20180620040164N59Darou darman Pars Co.24